Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Amoéba riceve il suo primo ordine da Koppert e conferma la sua trasformazione in società commerciale
Chassieu, March 12, 2026 (GLOBE NEWSWIRE) -- Amoéba riceve il suo primo ordine da Koppert e conferma la sua trasformazione in società commerciale Chassieu (Francia), 11 marzo 2026 – ore 18:00 -...
-
VERA BRADLEY ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS AND LEADERSHIP APPOINTMENTS
-
Company delivers sequential revenue and margin improvement within guidance in the fourth quarter; closes 2025 with top three market share positions1 across all competing categories Newly-announced...
-
New credit facility highlights Company’s ability to access lower-cost regional bank capital and secure among the most favorable terms in the industry, including an initial 9.5% annual interest rate...
-
Í viku 10 keypti Kvika banki hf. („Kvika“ eða „bankinn“) 11.800.000 eigin hluti að kaupverði 219.795.000 kr. eins og nánar er greint frá hér á eftir: DagsetningTímiKeyptir hlutirViðskiptaverð...
-
SANTA CLARA, Calif. and AMSTERDAM, March 11, 2026 (GLOBE NEWSWIRE) -- NVIDIA and Nebius Group N.V. (NASDAQ: NBIS) today announced a strategic partnership to develop and deploy the next generation of...
-
LOS ANGELES, March 10, 2026 (GLOBE NEWSWIRE) -- Acclaimed Hollywood actress Danielle Vasinova attended the red-carpet premiere of Taylor Sheridan’s epic western series 1923 for her work in season...
-
Received FDA clearance of Investigational New Drug application (IND) for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of 2026 Phase 1 study of PRT12396 in patients with...
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Pegasys Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering ...
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)